Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ANVS | Annovis Bio, Inc. | President and CEO, Director, 10%+ Owner | $6.52 M | Nov 20, 2023 | ||
LTRN | Lantern Pharma Inc. | Director | Oct 20, 2022 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|